| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/12/2003 | US20030109037 Central nervous system disorders |
| 06/12/2003 | US20030109036 Pancrea cells; antidiabetic agents |
| 06/12/2003 | US20030109035 Cell differentiation; tissue engineering; using activin, retinoic acid culture product |
| 06/12/2003 | US20030109026 Genetically modified tumor-targeted bacteria with reduced virulence |
| 06/12/2003 | US20030109008 Cell proliferation, cell differentiation; stem cells |
| 06/12/2003 | US20030108617 Use of a formulation made of or containing at least one dissimilated milk serum |
| 06/12/2003 | US20030108571 Administering extract of Eleutherococcus |
| 06/12/2003 | US20030108540 Inducing apoptosis in tissues; binding antibodies |
| 06/12/2003 | US20030108536 Therapy for bone marrow diseases; bubbing ozone, irradiation with ultraviolet radiation; antiinflammatory agents |
| 06/12/2003 | US20030108534 Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions |
| 06/12/2003 | US20030108530 Antisense inhibiting melanoma invasion and functional analogs thereof |
| 06/12/2003 | US20030108527 Maturation-promoting agent for immature dendrtic cells |
| 06/12/2003 | US20030108521 Adenovirus protein IX, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 06/12/2003 | US20030108517 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 06/12/2003 | CA2469104A1 Minor histocompatibility antigen ha-1: target antigen for immunotherapy of tumors |
| 06/12/2003 | CA2468944A1 Migration of hematopoietic stem cells and progenitor cells to the liver |
| 06/12/2003 | CA2467486A1 Vaccine |
| 06/12/2003 | CA2466697A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/12/2003 | CA2466413A1 Flavivirus ns1 subunit vaccine |
| 06/11/2003 | EP1318407A1 Use of aldose-1-epimerase (mutarotase) for the diagnosis and therapy of infections and sepsis |
| 06/11/2003 | EP1317927A1 Minor histocompatibility antigen HA-1: target antigen for immunotherapy of tumors |
| 06/11/2003 | EP1317560A1 Self-rearranging dna vectors |
| 06/11/2003 | EP1317536A2 Tnf receptor-like molecules and uses thereof |
| 06/11/2003 | EP1317489A1 A mixture of non-sulfated fucose-based oligosaccharides, a cosmetic or pharmaceutical composition comprising said mixture and its use in cosmetics or pharmacy |
| 06/11/2003 | EP1317488A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 06/11/2003 | EP1317476A2 Reagents for cell selection and methods of use |
| 06/11/2003 | EP1317288A2 Method and composition for treating tumors by selective induction of apoptosis |
| 06/11/2003 | EP1317282A2 VECTORS FOR MOLECULE DELIVERY TO CD11b EXPRESSING CELLS |
| 06/11/2003 | EP1317273A1 Use of il-6r/il-6 chimera in huntington's disease |
| 06/11/2003 | EP1317272A2 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 06/11/2003 | EP1317256A2 Pharmaceutical composition having modified carrier |
| 06/11/2003 | EP0954325B1 Method for the specific immunoadsorption of selected pathogenic factors in the treatment of aids |
| 06/11/2003 | EP0638119B1 Chimeric receptor genes and cells transformed therewith |
| 06/11/2003 | CN1423700A Multifunctional polypeptides comprising a binding site to and epitope of the NKG2D receptor complex |
| 06/11/2003 | CN1423692A Human Muellerian Duct-derived epithelial cells and methods of isolation and uses thereof |
| 06/11/2003 | CN1423642A Oxy-and amino-substituted tetrahydrofurl derivatives with antitumour activity |
| 06/11/2003 | CN1423565A 精子因子oscillogenin Sperm factor oscillogenin |
| 06/11/2003 | CN1423563A Pancreatic stem cells and their use in transplantation |
| 06/11/2003 | CN1423528A Nutritional modules |
| 06/11/2003 | CN1422661A Chinese medicinal proprietary for treating hemiplegic by apoplexia-Fuzhengpiantanwan |
| 06/11/2003 | CN1422660A Chinese medicine for treating epilepsia and preparation method thereof |
| 06/11/2003 | CN1422650A Ointment for treating various skin diseases and preparation method thereof |
| 06/11/2003 | CN1422642A Series Chinese medicinal composition for treating tumor |
| 06/11/2003 | CN1422631A Chinese medicine for treating face acne |
| 06/11/2003 | CN1422628A Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia |
| 06/11/2003 | CN1111066C Musk plaster for bone-set |
| 06/11/2003 | CN1111065C Plaster for curing mastosis |
| 06/11/2003 | CN1111064C Hepatitis treating medicine and its production process |
| 06/11/2003 | CN1111059C Medicine for treating asthma |
| 06/11/2003 | CN1111058C Vesania-treating medicine |
| 06/11/2003 | CN1111055C Ichthyosis treating cream and its preparation |
| 06/11/2003 | CN1111051C Medicine for treating cough and asthma |
| 06/11/2003 | CN1111050C Chinese medicine for curing streptomycin toxic deafness |
| 06/11/2003 | CN1111049C Medicine for curing angitis and its preparing method |
| 06/11/2003 | CN1111048C Combined medicine for curing alopecia areata |
| 06/11/2003 | CN1111046C Chinese medicine preparation for curing postpartum disease of woman |
| 06/11/2003 | CN1111045C Chewing medicine for treating facial paralysis and its preparing process |
| 06/11/2003 | CN1111043C Medicine for treating protrusion of lumber vertebral disc and its preparation |
| 06/11/2003 | CN1111042C Medicine for treating cardiac and cerebral vascular diseases and its preparation |
| 06/11/2003 | CN1111041C Plaster for treating cancer and tumor |
| 06/11/2003 | CN1111040C Hepatitis treating medicine |
| 06/11/2003 | CN1111038C Chinese medicine for curing thrombotic disease |
| 06/11/2003 | CN1111037C Bone and muscle bolus |
| 06/11/2003 | CN1111036C Medicine for treating benign goiter |
| 06/11/2003 | CN1111035C Chinese medicine for curing gastroenteritic diseases |
| 06/11/2003 | CN1111034C Gel for treating tooth anaphylactia |
| 06/11/2003 | CN1111033C Psoriasis treating medicine |
| 06/10/2003 | US6576756 Nucleotide sequences coding polypetide for use in the diagnosis and treatment of cancer |
| 06/10/2003 | US6576658 Compositions and uses of dictyostatin compounds |
| 06/10/2003 | US6576466 Activation; separation |
| 06/10/2003 | US6576465 Human bone accessory cells |
| 06/10/2003 | US6576464 Methods for providing differentiated stem cells |
| 06/10/2003 | US6576456 Chimeric adenovirus fiber protein |
| 06/10/2003 | US6576433 Method for identification of cell growth or differentiation factors |
| 06/10/2003 | US6576252 Composition providing calming, stress hormone regulating and immune stimulation effect, which comprises component including combination of linoleic and linolenic acids in specified ratio, and component taken from flavonoid group |
| 06/10/2003 | US6576249 Contacting demineralized bone matrix with water at elevated temperature to aid dissolution to provide supernatant having specified viscosity, cooling to room temperature, mixing with bone matrix particles to form suspension |
| 06/10/2003 | US6576241 Crude drug extracts, and methods for making and standardizing same |
| 06/10/2003 | US6576234 Reovirus for the treatment of neoplasia |
| 06/10/2003 | US6576229 Administering synthetic phenolic polymeric material prepared by dissolving phenolic compound in aqueous solution, adjusting pH to between 8 and 11, oxidizing, polymerizing, adding water soluble compound, removing low molecular weight material |
| 06/10/2003 | CA2234208C Influenza vaccine |
| 06/10/2003 | CA2143416C Inhibitor of collagen-stimulated platelet aggregation |
| 06/10/2003 | CA2065572C Novel complex phosphorous lipid based dietetic compositions and their use in sleep disorders |
| 06/05/2003 | WO2003046580A1 Assay for screening candidate drugs for the treatment of inflammatory diseases |
| 06/05/2003 | WO2003046563A1 Food intolerance immunoassay |
| 06/05/2003 | WO2003046191A1 Method for culturing dendritic cells |
| 06/05/2003 | WO2003046189A1 Flavivirus vaccine delivery system |
| 06/05/2003 | WO2003046181A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 06/05/2003 | WO2003046171A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 06/05/2003 | WO2003046170A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 06/05/2003 | WO2003046161A2 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 06/05/2003 | WO2003046141A2 Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells |
| 06/05/2003 | WO2003045979A2 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 06/05/2003 | WO2003045905A1 Hydroperylene derivatives |
| 06/05/2003 | WO2003045427A2 Pharmaceutical composition for inducing an immune response in a human or animal |
| 06/05/2003 | WO2003045417A1 Antiglaucomatous agent and use thereof |
| 06/05/2003 | WO2003045405A2 Lactic acid bacteria and their use for treating and preventing cancer |
| 06/05/2003 | WO2003045335A2 Stem cell screening and transplantation therapy for hiv infection |
| 06/05/2003 | WO2003045226A2 Eb matrix production from animal tissue and its use for tissue repair |
| 06/05/2003 | WO2003045153A1 Combination bacteriolytic therapy for the treatment of tumors |
| 06/05/2003 | WO2003029418A3 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |